4Filing Date: Feb 18, 2026
Gilead (GILD)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001310204-26-000006
Total Value$463.3K
Trades1
Insiders1
Transaction Details
Dickinson Andrew D
Chief Financial Officer·Direct
Sell · Dispose
Common Stock
Shares-3.00K
Price$154.43
Total Value$463.3K
Shares Owned After167.78K
Transaction DateFeb 17, 2026
10b5-1
Footnotes ▸
The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024. | Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.
Post-Transaction Holdings
Dickinson Andrew D · Chief Financial Officer
| Security | Shares | Change |
|---|---|---|
| Common Stock | 167.78K | -3.00K (-1.76%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-02-17
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: GILEAD SCIENCES, INC. (GILD)
CIK: 0000882095
--- Reporting Owner ---
Name: Dickinson Andrew D
CIK: 0001310204
Role: Officer (Chief Financial Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-02-17 | Code: S (Open market sale)
Shares: -3,000 | Price: $154.43
Total Value: $463,290.00
Shares Owned After: 167,779 | Ownership: D (Direct)
Footnotes:
[F1] The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.
[F2] Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.
--- Footnotes (Complete Index) ---
F1: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.
F2: Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.
--- Signature ---
/s/ /s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson (2026-02-18)